168 related articles for article (PubMed ID: 35848069)
1. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Signal detection and preventability from Vietnam National pharmacovigilance database.
Huong PT; Ha TN; Nhu TTQ; Nga NTH; Anh NH; Hoa VD; Binh NQ; Anh NH
J Clin Pharm Ther; 2022 Dec; 47(12):2014-2019. PubMed ID: 35848069
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
[TBL] [Abstract][Full Text] [Related]
3. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
[TBL] [Abstract][Full Text] [Related]
4. Association of human leukocyte antigen variants and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis.
Li X; Zhao Z; Sun SS
Am J Health Syst Pharm; 2017 May; 74(9):e183-e192. PubMed ID: 28438823
[TBL] [Abstract][Full Text] [Related]
5. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.
Lebrun-Vignes B; Guy C; Jean-Pastor MJ; Gras-Champel V; Zenut M;
Br J Clin Pharmacol; 2018 Feb; 84(2):331-338. PubMed ID: 28963996
[TBL] [Abstract][Full Text] [Related]
6. Colistin-associated Stevens-Johnson syndrome and toxic epidermal necrolysis reactions: a retrospective case-non-case pharmacovigilance study.
Tang R; Lopes VL; Caffrey AR
Expert Opin Drug Saf; 2022 Aug; 21(8):1121-1126. PubMed ID: 35196183
[TBL] [Abstract][Full Text] [Related]
7. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
[TBL] [Abstract][Full Text] [Related]
8. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.
Lu N; Rai SK; Terkeltaub R; Kim SC; Menendez ME; Choi HK
Semin Arthritis Rheum; 2016 Oct; 46(2):253-258. PubMed ID: 27217070
[TBL] [Abstract][Full Text] [Related]
10. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization.
Zheng Y; Zhou W; Guo X; Chi L; Chen C; Guo Z; Liang J; Wei L; Chen X; Ye X; He J
Expert Opin Drug Saf; 2022 Aug; 21(8):1127-1133. PubMed ID: 35196201
[TBL] [Abstract][Full Text] [Related]
12. Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: Subgroup analysis based on a Japanese spontaneous database.
Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K; Hosohata K
J Clin Pharm Ther; 2019 Oct; 44(5):775-779. PubMed ID: 31231846
[TBL] [Abstract][Full Text] [Related]
13. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
[TBL] [Abstract][Full Text] [Related]
14. Allopurinol-Induced Severe Cutaneous Adverse Drug Reactions: An Analysis of Spontaneous Reports in Malaysia (2000-2018).
Lee SC; Wo WK; Yeoh HS; Mohamed Ali N; Hariraj V
Ther Innov Regul Sci; 2021 May; 55(3):514-522. PubMed ID: 33393015
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea.
Kang MG; Sohn KH; Kang DY; Park HK; Yang MS; Lee JY; Kang HR
Yonsei Med J; 2019 Feb; 60(2):208-215. PubMed ID: 30666843
[TBL] [Abstract][Full Text] [Related]
16. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.
Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717
[TBL] [Abstract][Full Text] [Related]
17. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
Tohkin M; Kaniwa N; Saito Y; Sugiyama E; Kurose K; Nishikawa J; Hasegawa R; Aihara M; Matsunaga K; Abe M; Furuya H; Takahashi Y; Ikeda H; Muramatsu M; Ueta M; Sotozono C; Kinoshita S; Ikezawa Z;
Pharmacogenomics J; 2013 Feb; 13(1):60-9. PubMed ID: 21912425
[TBL] [Abstract][Full Text] [Related]
18. Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.
Oshikoya KA; Ogunyinka IA; Ogar CK; Abiola A; Ibrahim A; Oreagba IA
Ther Adv Drug Saf; 2020; 11():2042098620905998. PubMed ID: 32110375
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.
Ordoñez L; Salgueiro E; Jimeno FJ; Manso G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2732-7. PubMed ID: 26221907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
